The actor was diagnosed eight years ago, according to his caretaker.

FDA gives go-ahead to D1/D5 dopamine agonist tavapadon ...

Sept 25 (Reuters) - The US Food and Drug Administration has approved AbbVie's treatment for Parkinson's disease in adults, ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first ...

A recent study from CSIR-CCMB reveals how viral infections may trigger amyloid formation leading to Parkinson's disease.

A new study by CSIR-CCMB researchers has elucidated the molecular mechanisms by which viral infections, particularly RNA viruses like Influenza and COVID-19, can accelerate the formation of amyloid ...

A new study by scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad has revealed how viral ...

New information is emerging about Dennis Haskins‘ health following his death at 75. Kimberly Snow, a friend and caretaker of the Saved by the Bell alum, told The New York Times following news of his ...

Finding Joy With Parkinson's is Sept. 30 at the Woodman's Center in Janesville. It is intended as an outreach to show off the ...

Juvmo (tavapadon) offers a novel, selective D1/D5 dopamine receptor partial agonist mechanism for early monotherapy and adjunctive treatment in Parkinson disease.

AbbVie ( ABBV) announced that the U.S. FDA has approved JUVMO (tavapadon) tablets for the treatment of adults with Parkinson's disease, providing a new oral treatment option for a progressive ...

Michael J. Fox continued turning a personal battle into a powerful push for a Parkinson’s cure. More than two decades after going public with his diagnosis, the actor remained determined to speed up ...